Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Vitamin D
85%
Placebo
44%
Cholecalciferol
40%
Infliximab
40%
Diarrhea
40%
Bile Acid
40%
Colesevelam
24%
Obeticholic Acid
20%
Ergocalciferol
20%
Programmed Death 1 Receptor
20%
Calcifediol
20%
Clinical Trial
20%
Alcohol Liver Cirrhosis
20%
Fidaxomicin
20%
Combination Therapy
20%
Feces microflora
20%
Clostridium Difficile Infection
20%
Malabsorption
20%
Vancomycin
20%
Retrospective Study
20%
Disease Activity
13%
Remission
11%
25 Hydroxyvitamin D
10%
Adverse Event
7%
Disease Course
6%
Calcitriol
6%
Inflammation
6%
C Reactive Protein
5%
Peptoclostridium difficile
5%
Medicine and Dentistry
Diarrhea
60%
Bile Acid
50%
Placebo
22%
Colesevelam
20%
Clostridium Difficile Infection
20%
Fecal Microbiota Transplantation
20%
Wilson's Disease
20%
Clinical Trial
20%
Hemolytic
20%
Extracorporeal Circulation
20%
Vancomycin
20%
Fidaxomicin
20%
Combination Therapy
20%
Retrospective Study
20%
Bile Acid Malabsorption
20%
Fibroblast Growth Factor 19
7%
Adverse Event
7%
Loperamide
5%
Sequestering Agent
5%
Mental Health
5%
Penicillamine
5%
Biochemical Marker
5%
Disease Severity
5%
Fulminant
5%
Multiple Organ Dysfunction Syndrome
5%
Liver Support
5%
Acetylcysteine
5%
Liver Dialysis
5%
Liver Transplantation
5%
Emergency Medical Technician
5%
Peptoclostridium difficile
5%
Biochemistry, Genetics and Molecular Biology
Vitamin D
46%
T Cell
32%
Cholecalciferol
29%
Eicosanoid Receptor
20%
Interleukin-6
20%
Dendritic Cell
20%
Calcifediol
20%
CD4
15%
Immune Response
6%
CD25
5%
CD69
5%
